Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Vasopressin recalled?

Yes — there is an active recall. 6 ongoing FDA recalls mention Vasopressin (12 total). Check the affected lots below.

Most common reason: Wrong potency / content (6 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Vasopressin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Vasopressin recalls in 2026

3 initiated in 2026, 12 in total — newest first
Class II · Moderate risk

Vasopressin

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 0338-9647-12 D-0819-2026
Class II · Moderate risk

Vasopressin

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 0338-9640-12 D-0811-2026
Class II · Moderate risk

Vasopressin Injection

Subpotent product in addition to having out-of-specification results for impurities.

Terminated Wrong potency / content American Regent, Inc. NDC 0517-1030-01 D-0507-2024
Class II · Moderate risk

Vasostrict

Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.

Ongoing Wrong potency / content Par Sterile Products LLC D-0232-2024